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Twenty-three Lactobacillus strains of dairy originwere evaluated for some functional properties relevant to their use as probiotics. A
preliminary subtractive screening based on the abilities to inhibit the growth of microbial pathogens and hydrolyze conjugated bile
salts was applied, and six strains were selected for further characterization including survival under gastrointestinal environmental
conditions, adhesion to gut epithelial tissue, enzymatic activity, and some safety properties. All selected strains maintained elevated
cell numbers under conditions simulating passage through the human gastrointestinal tract, well comparable to the values obtained
for the probiotic strain Lactobacillus rhamnosusGG, and were able to adhere to Caco-2 cells to various extents (from 3 to 20%). All
strains exhibited high aminopeptidase, and absent or very lowproteolytic and strong𝛽-galactosidase activities; nonewas found to be
haemolytic or to produce biogenic amines and all were susceptible to tetracycline, chloramphenicol, erythromycin, ampicillin, and
amoxicillin/clavulanic acid. Our results indicate that the Lactobacillus strains analyzed could be considered appropriate probiotic
candidates, due to resistance to GIT simulated conditions, antimicrobial activity, adhesion to Caco-2 cell-line, and absence of
undesirable properties. They could be used as adjunct cultures for contributing to the quality and health related functional
properties of dairy products.
1. Introduction
Lactic acid bacteria (LAB) are widespread in nature and
are one of the major microbial groups involved in the
fermentation of different types of food. They represent the
dominant microorganisms in milk and milk products where
they play important roles during both manufacture and
ripening. LAB possess a large number ofmetabolic properties
that are responsible for the organoleptic characteristics of
the final product as well as its preservation and microbial
safety [1]. They are also known for their potential health and
nutritional benefits and therefore are considered “probiotics”
or “live microorganisms which upon ingestion in adequate
amounts confer health benefits to the host” [2].
As a result of increasing awareness of the close inter-
relationship between health and diet, special attention is
presently given to functional properties of LAB associated
with traditional fermented products. These foods could
represent alternative sources of novel probiotic candidates
with physiological and functional properties for potential
biotechnological use in the manufacturing of functional
products in which the probiotic cultures are more active and
protected from the gastrointestinal stress.
Among food ecosystem, cheese has some intrinsic chem-
ical and physical characteristics (high pH, buffering capac-
ity, solid consistency, high fat content, and high nutrient
availability) that make it suitable for delivery of viable
probiotic microorganisms into the human intestine [3]. Raw
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milk and traditional cheeses are rich environments with a
varied and complex autochthonous microbiota composed
of diverse group of microorganisms, including LAB, which
contribute to the biopreservation and the development of
organoleptic properties of the final product. LAB may play
different roles in cheese-making; some species designated as
starter LAB (SLAB) participate in the fermentation process,
whereas some others indicated as nonstarter LAB (NSLAB)
are implicated in the maturation process [4].
Among LAB, Lactobacillus strains have been extensively
exploited for their probiotic properties [5] and are applied as
adjunct cultures in various types of food products [6].
Lactobacilli are generally regarded as safe (GRAS) due
to their long history of safe use and their presence in the
intestinal microbiota of humans, and several species have
received the qualified presumption of safety (QPS) status
[7, 8].
Recently an increasing interest was paid to the possibility
that strains belonging to species such as Lactobacillus plan-
tarum, L. paracasei, and L. brevis,which constitute themajor-
ity of NSLAB found in most ripened cheese varieties, may
play a role as health promoters, beyond their technological
function [9].
To perform their probiotic action these bacteria must
arrive at the intestinal tract alive. This requires their survival
during food processing, product maturation, and shelf-
life and, after consumption, their resistance to the acidic
conditions of the stomach as well as to bile salts in the small
intestine [10].
As a part of a larger study involving the selection and
characterization of new probiotic candidates, 23 autoch-
thonous Lactobacillus strains of dairy origin were investi-
gated for some functional properties relevant to their use
as probiotic cultures. Antagonism toward microbial path-
ogens, ability to deconjugate bile salts, survival in the
gastrointestinal tract, adhesion capability to intestinal epi-
thelial cells, enzymatic activities, and some safety features
such as hemolytic activity, antimicrobial resistance, and
production of biogenic amines were in vitro analyzed.
2. Materials and Methods
2.1. Bacterial Strains and Growth Conditions. A total of 23
Lactobacillus strains (10 L. paracasei, 9 L. plantarum, and 4
L. brevis) isolated from raw milk and artisanal ewes’ cheeses
were included in this study.The strains were identified on the
basis of phenotypic tests and genetic analysis based on poly-
merase chain reaction amplification using species-specific
primers derived from 16S rRNA sequences, as previously
reported [11]. The strains were maintained at −20∘C in MRS
broth (Microbiol, Cagliari, Italy) with 15% (v/v) glycerol and
propagated three times in MRS broth for activation prior
to experimental use. Listeria monocytogenes ATCC 7644,
Escherichia coli ATCC 35150, Enterococcus faecalis ATCC
29212, SalmonellaTyphimuriumATCC 14028, Staphylococcus
aureus ATCC 25923, and Candida albicans ATCC 10231
were used as indicators. All indicator strains were stored
on nutrient broth (Microbiol) plus 20% (v/v) glycerol at
−20∘C. Before use, theywere subcultured twice in appropriate
medium.
2.2. Antimicrobial Activity. The strains were screened for
antimicrobial compounds production against the indicator
strains using an agar spot method [12]. Overnight cultures of
Lactobacilli were spotted onto the surface of MRS agar (1.2%
(w/v) agar—0.2% (w/v) glucose) plates, which were then
incubated anaerobically for 24 h at 37∘C.The indicator strains
were inoculated into 7mL of soft agar medium (nutrient
broth containing 0.7% w/v agar) to a final concentration of
approximately 107 colony forming unit (cfu)/mL; then the soft
media were poured on the plates. After 24 h of incubation
at the optimal growth temperature and atmosphere for the
indicator strains, inhibition halos were measured. The width
of the clear zone (𝑅) was calculated as follows: 𝑅 = (𝑑Inhib −
𝑑Spot)/2, where 𝑑Inhib is the diameter of the zone without
pathogen growth and 𝑑Spot is the diameter of the spot.
2.3. Bile Salt Hydrolase Activity. Bile salt hydrolase (BSH)
activity was screened by spotting in duplicate 10 𝜇L of
cultures grown overnight in MRS broth on the surface of
MRS agar plates supplemented with 0.5% (w/v) sodium salt
taurodeoxycholic acid (TDCA, Sigma, Milano, Italy) or 0.2%
(w/v) glycodeoxycholic acid (GDCA, Sigma) and 0.37 g/L of
CaCl
2
[13]. Plates were incubated in anaerobic conditions at
37∘C for 72 h.The presence of halos around colonies (inMRS-
GDCA) or white opaque colonies (in MRS-TDCA) indicated
BSH activity. MRS agar plates without supplementation were
used as negative controls. Enterococcus faecalis ATCC 14433
was used as BSH-positive strain.
2.4. In Vitro Resistance to Gastrointestinal Conditions. Transit
tolerance in the upper GIT was assessed using an in vitro
model simulating gastric and pancreatic juices (simulated
stomach-duodenum passage, SSDP), as reported by Vizoso
Pinto et al. [14]. The strains were inoculated to a final
concentration of approximately 2.5 × 108 cfu/mL in 10mL of
simulated gastric juice (6.2 g/L NaCl, 2.2 g/L KCl, 0.22 g/L
CaCl
2
, 1.2 g/L NaHCO
3
, 0.3% pepsin, and pH 3.0) and
incubated at 37∘C in a shaking water bath (Dubnoff 750, Asal,
Milano, Italy) to simulate peristalsis. After 90min, 17.5mL of
synthetic duodenum juice (6.4 g/L NaHCO
3
, 0.239 g/L KCl,
1.28 g/L NaCl, and 0.1% pancreatin), adjusted to pH 7.4 with
5M HCl, and 4mL of 10% (w/v) oxgall (Sigma) were added
to the cell suspensions to simulate passage into the upper
intestinal tract [15]. After 0, 90, and 180min of incubation, the
survival rate was determined by the plate method using MRS
incubated anaerobically at 37∘C for 48 h. The experiments
were repeated twice and results are expressed as the mean log
cfu/mL.
2.5. Adhesion Properties to Human Cell Line. The human
colonic carcinoma cell line Caco-2 (ECACC, Salisbury,
UK) was routinely cultured in Dulbecco’s modified Eagle’s
minimal essential medium DMEM (Sigma), supplemented
with 10% (w/v) foetal bovine serum (FBS, Sigma), 1% (w/v)
nonessential amino acids solution (Sigma), and antibiotic
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solution (100U/mL penicillin, 100 𝜇g/mL streptomycin).
Cells were maintained in T-75 culture flasks at 37∘C in a 5%
CO
2
atmosphere. For adhesion assay, the Caco-2 cells were
seeded at a concentration of 105 cells/well in 6-well tissue
culture plates (Falcon) to obtain confluence and cultured
for 20 days prior to use in adhesion assay. The cell culture
medium was changed on alternate days and replaced by
fresh DMEM supplemented with 2% (w/v) FBS and without
antibiotic at least 1 h before the adhesion assay. A 1mL
aliquot of Lactobacillus suspension (108 ufc/mL in phosphate
buffered saline, PBS) was added to each well of the tissue
culture plate and incubated at 37∘C in 5%CO
2
atmosphere for
3 h. Afterwards, the cells were washed three times with 1mL
of PBS in order to remove nonadherent bacteria and lysed
by addition of Triton X 100 (0.05% solution) for 10min; then
appropriate dilutions were plated onMRS agar. Adhesionwas
expressed as the percentage of bacteria adhered to Caco-2
cells compared to the initial amount of bacteria.
2.6. Enzymatic Activities. Enzymatic activities of Lactobacil-
lus strains were evaluated by using the API ZYM galleries
(BioMe´rieux, Itay) as described by the manufacturer. The
results were graded from 0 to 5 by comparing the colour
developed within 5min with the API-ZYM colour reaction
chart.The results were expressed in nanomoles of hydrolysed
substrate, from the intensity of the reactions obtained, in the
range 0 (no activity) to 5 (40 or more nanomoles liberated),
following the manufacturer’s instructions.
2.7. Safety Assessment. The method of Bover-Cid and Holz-
apfel [16] was used to screen Lactobacillus strains for the
production of biogenic amines. Briefly, the test strains were
subcultured twice at 24 h intervals in MRS broth containing
1% of each precursor amino acid: tyrosine disodium salt, l-
histidine monohydrochloride, l-ornithine monohydrochlo-
ride, and lysine monohydrochloride (Sigma), and 0.005%
pyridoxal-5-phosphate (Sigma) as a codecarboxylase factor.
All strains were then streaked in duplicate on decarboxylase
medium plates each containing only one of the abovemen-
tioned amino acids and bromocresol purple as pH indicator
and incubated for 4 days in anaerobic conditions at 37∘C.
Decarboxylase medium without amino acids was used as
control. A colour change from brown to purple in the
medium indicated an increase in pH and was considered a
positive result.
Antibiotic susceptibilitytesting was carried out by disc
diffusion method according to the Clinical and Labora-
tory Standards Institute (CLSI) guidelines [17] but Mueller-
Hinton agar was replaced by MRS agar (Microbiol). The
following antibiotics (Oxoid or BBL) were tested: ampicillin
(AM; 10 𝜇g), amoxicillin/clavulanic acid (AmC; 30 𝜇g), van-
comycin (VA; 30 𝜇g), teicoplanin (TEC; 30𝜇g) (inhibitors of
cell wall synthesis), tetracycline (TE; 30 𝜇g), streptomycin (S;
10 𝜇g), kanamycin (K; 30 𝜇g), gentamicin (GM; 10 𝜇g), chlo-
ramphenicol (C; 30𝜇g), erythromycin (E; 15𝜇g) (inhibitors of
protein synthesis), ciprofloxacin (CIP; 5𝜇g), and rifampicin
(RA; 30 𝜇g) (inhibitors of nucleic acids). A suspension from
fresh overnight cultures with a density of McFarland 0.5 in
buffered saline was plated onMRS agar plates; then antibiotic
discs were dispensed onto the plates. After incubation at
37∘C for 24 h in anaerobiosis, the diameters of the bacterial
free-zone were measured and results expressed in terms of
resistance according to the interpretative criteria issued by the
CLSI [18].
Haemolytic activity was determined by streaking the
strains on Columbia Blood (Microbiol) agar plates sup-
plemented with 5% defibrinated sheep blood after 48 h of
incubation at 37∘C.The haemolytic reaction was recorded by
observation of a clear zone of hydrolysis around the colonies
(𝛽-haemolysis), a partial hydrolysis and greenish zone (𝛼-
haemolysis), or no reaction (𝛾-haemolysis).
2.8. Statistical Analysis. Statistical analysis of datawas carried
out usingGraphPad Prism Statistics software package version
3.00 (GraphPad Prism Software Inc., San Diego, CA, USA).
One-way ANOVA followed by Bonferroni test was used to
determine significant differences of viability of the Lactobacil-
lus strains during SSDP treatment and with respect to the
adhesion ability. Data were analysed at the significance level
of 𝑃 < 0.05.
3. Results and Discussion
A preliminary subtractive screening based on the abilities
to inhibit the growth of microbial pathogens and hydrolyse
conjugated bile salts was applied to the strains. As shown
in Table 1, most strains were able to inhibit the growth of
L. monocytogenes, S. aureus, and E. coli O157:H7 with clear
inhibition zones of more than 6mm in agar-spot plates. A
lower activity was detected against E. faecalis, while one
strain showed an inhibition zone of 4mm against C. albicans
ATCC 10231. Such broad antagonistic activity of Lactobacillus
towards different pathogens has been reported [19, 20];
however, 27 strains of L. plantarum isolated from cheese
showed no activity against selected indicator pathogens [21].
LAB are known to produce many different substances
with antimicrobial activity, including the major metabolic
end products such as organic acids, hydrogen peroxide,
ethanol, and bacteriocins [22].When the strains with the best
inhibitory activity in the agar spot-test were further tested
using the well-diffusion assay, to investigate the presence
of bacteriocin-like compounds, no inhibitory activity was
observed (data not shown), presumably indicating that the
production of organic acids was responsible for the observed
antimicrobial effect. The inhibitory effect of hydrogen perox-
ide was excluded due to incubation in anaerobic conditions.
BSH activity is a relevant property for probiotic strains to
survive the toxicity of conjugated bile salts in the duodenum
[23]. In our study, while all strains were able to grow in
the presence of conjugated bile salts after 72 h of incubation,
only five (L. plantarum 11/20966, 4/16868, 19/20711 and
L. paracasei 62LP39, 1A6M) demonstrated also the ability
to hydrolyze both sodium glycodeoxycholate (GDCA) and
sodium taurodeoxycholate (TDCA), and four were able to
deconjugate only GDCA, as indicated by the BSH test on
agar plates. Some authors have shown that in Lactobacilli
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Table 1: Antimicrobial activity against themicrobial pathogens tested, bile salt hydrolase (BSH) activity, and raffinose fermentation of selected
potential probiotic Lactobacillus strains isolated from Sardinian dairy products.












ATCC 10231 TDCA GDCA Raffinose
∗
L. paracasei 62LP39 7.5 9 6.5 1.5 >10 2 + + +
L. paracasei 8/18710 5 9 7.5 2 >10 1.5 − − −
L. paracasei 1A6M 6 7.5 6 2 >10 1 + + +
L. paracasei 3A1M 3 6 5 1 7.5 0 − − −
L. paracasei 5/22019 6.5 8.5 5 0.5 7.5 0 − + −
L. paracasei 2C6M 6 5 6 0.5 7.5 0 − − −
L. paracasei 60LP37 7.5 9 9 1 >10 0.5 − − −
L. paracasei 2A11 6.5 9 5 0.5 >10 0 − − −
L. paracasei 6B1M 5 7.5 6 1 >10 0.5 − − −
L. paracasei 2B1M 5 9 6 1.5 >10 1 − − −
L. plantarum 11/20966 7 9 7.5 1 >10 2.5 + + +
L. plantarum 19/20711 7.5 9 7.5 2 >10 2 + + +
L. plantarum 4/16868 10 10 9 2.5 >10 2 + + +
L. plantarum 8C1M 5 5 6 1.5 >10 0 − + −
L. plantarum 9FS15 6 1.5 5 1.5 >10 1.5 − − −
L. plantarum 28SP1 4.5 2.5 3 1 >10 1.5 − − −
L. plantarum 2AFS11 6.5 9 5 1 >10 0.5 − − −
L. plantarum 5FS12 6 5 6 0.5 7.5 0 − − −
L. plantarum 12LP13 5 7.5 6 1 >10 0 − − −
L. brevis 1C3M 6.5 7.5 6 0.5 >10 4 − + −
L. brevis 9/11B 5 9 5 0.5 >10 0.5 − + −
L. brevis 21FS1B 5 7 5 1 >10 0.5 − − −
L. brevis 9A3M 4 5 5 0 >10 0.5 − − −
∗Determined by API-50 CHL galleries (bioMe´rieux).
the resistance to bile salts toxicity is not related to hydrolase
activity [21, 24–26]. Other mechanisms, alternative to BSH,
could be involved in counteract bile damage, as suggested by
Noriega et al. [27].
BSH activity is frequently observed in specific groups of
bacteria like Lactobacillus, Bifidobacterium, and Enterococcus
isolated from the gastrointestinal tract (GIT): it has been
reported for L. plantarum [14, 28] but not for L. paracasei
strains [26, 29]. Presently its role is controversial since it has
been reported to act either positively in lowering of serum
cholesterol [30] or negatively in increasing the level of unde-
sirable deconjugated bile salts [31]. However, the bacterial
genera most frequently used as probiotics (Bifidobacteria and
Lactobacilli) are not capable of dehydroxylating deconjugated
bile salts [32, 33] and so the majority of the breakdown
products may be precipitated and excreted with feces [34].
On the other hand, BSH activity by a probiotic bacterium
may be desirable since it increases the intestinal survival and
persistence of producing strains, which in turn increases the
overall beneficial effects associated with the strain [35].
Among the BSH positive strains, five showing the ability
to ferment the trisaccharide raffinose, known for its prebiotic
activity, and one with a high antagonistic activity against
C. albicans ATCC 10231 were selected for further functional
characterization including in vitro tests to assess their survival
under gastrointestinal environmental conditions and adhe-
sion to gut epithelial tissue and to determine the enzymatic
activity and some safety properties.
The survival responses of the strains, after 90 and
180min of exposure to different gastrointestinal conditions,
are shown in Table 2. The probiotic strain L. rhamnosus GG
was included in the study for comparison purpose. All strains
retained high viability during simulated gastric juice (pH 3.0)
transit for 90min, and no significant reduction (𝑃 > 0.05)
was found for any of the strains after exposure to artificial
duodenum juice (pH 8.0). The strains L. paracasei 62LP39
and L. plantarum 11/20966 and 4/16868 presented the best
survival rates values with more than 98% surviving cells.
Exposure to gastric and intestinal fluids is the main envi-
ronmental stress that decreases viability of ingested probiotics
[36]. All selected strains maintained elevated cell numbers
under conditions simulating passage through the human
gastrointestinal tract, well comparable to the values obtained
for the probiotic strain L. rhamnosus GG. The survival rates
were above 90% after 3 h despite the high bile concentration
(more than 1%) used in the test. These results are consistent
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Table 2: Resistance of Lactobacillus strains to simulated stomach duodenum-passage (SSDP). The values are reported as log cfu/mL (mean
± E.S.).
Species Initial mean count Survival after90min at pH 3.0
Survival after 180min of
which 90min in 5% oxgall
Strain
L. paracasei
62LP39 8.33 ± 0.03 8.67 ± 0.11 8.66 ± 0.84
1A6M 8.49 ± 0.07 8.08 ± 0.02 7.47 ± 1.39
L. plantarum
11/20966 8.66 ± 0.15 9.70 ± 0.91 8.62 ± 0.17
19/207111 8.58 ± 0.13 8.58 ± 0.3 7.76 ± 0.35
4/16868 8.21 ± 0.03 8.06 ± 0.2 8.47 ± 0.2
L. brevis
1C3M 8.59 ± 0.23 8.75 ± 0.05 8.39 ± 0.14
L. rhamnosus GG 8.59 ± 0.02 9.03 ± 0.18 8.23 ± 0.59
with those previously reported for other potentially probiotic
strains belonging to L. paracasei [26] and L. plantarum [21]
and correlate well with those obtained for BSH activity.
The adhesion ability of Lactobacillus strains is reported
in Figure 1. All strains were able to adhere to Caco-2 cells
to various extents (ranging from 3 to 20%), confirming
that adhesion is a strain-specific property. Three strains
showed significantly higher adherence to Caco-2 cells than
L. rhamnosus GG (𝑃 < 0.05). L. paracasei 62LP39 was the
most adhesive strain since approximately 20% of the added
bacteria were bound to Caco-2 cells, followed by L. brevis
1C3M (14%) and L. plantarum 11/20966 (10.5%). A lower
adhesion rate was observed for the strain L. paracasei 1A6M
(3%).Thepercentage of adhesion ofL. rhamnosusGG, used as
positive control, was similar to those obtained with the same
strain in other studies [37, 38] but lower than the values found
by Xu et al. [39]. L. plantarum strains have been shown to
adhere more efficiently to Caco-2 cells than L. paracasei or L.
brevis [29, 38], althoughToumola and Salminen [37] obtained
an adhesion percentage at the level of 6.7%. Other authors
observed that L. paracasei strains were effective in reducing
adhesion of Salmonella to Caco-2 cells in competitive assays,
in spite of their low adherence ability [40–42].
Several in vitro studies suggested that probiotic adhesion
may interfere with the adherence of pathogens, exerting a
barrier against pathogen colonization through competitive
exclusion mechanisms [39, 40].
Enzymatic characterization of the selected strains was
carried out in order to evaluate their potential for using as
adjunct cultures in the manufacturing of probiotic cheese
and is reported in Table 3. All strains exhibited high amino-
peptidase activity (leucine and valine arylamidase) while
esterase and lipase activities were generally moderate to low.
The proteolytic and N-acetyl-𝛽-glucosaminidase activities
were absent or very low. All strains exhibited strong 𝛽-
galactosidase and moderate-to-high 𝛼-galactosidase activ-
ities, which are responsible for the hydrolysis of lactose
and raffinose, respectively. None of the strains showed 𝛽-


























































Figure 1: Adhesion ability to Caco-2 human colon cell lines of dairy
Lactobacillus strain (mean±E.S. of three independent experiments).
Mean values with different superscript letters were significantly
different at 𝑃 < 0.05.
Overall, the enzymatic profiles of our strains are similar
to those reported by other authors particularly for the species
L. plantarum [42–44]. Mathara et al. [43] could not detect
any 𝛽-galactosidase in 14 L. paracasei isolates and Herreros
et al. [42] found a certain degree of activity in two strains
of L. brevis. Strains with low proteinase, high peptidase,
and low esterase-lipase activities may be useful in reducing
bitterness and improving body and texture defects [43, 44].𝛽-
galactosidase activity is an important feature for strains to be
used as probiotics, since it may be useful in improving lactose
tolerance in the gut [45].The lack of 𝛽-glucuronidase activity
is an important trait, as well, since its negative role has been
suggested in increasing the risk of carcinogenesis [46].
In order for a strain to be used as probiotic culture, it
should be evaluated for the presence of virulence determi-
nants to determine what potential risks might be involved
in its use. Biogenic amines are produced by LAB during the
6 BioMed Research International
Table 3: Enzymatic profiles of selected dairy Lactobacillus strains assayed by the API-ZYM system.
Enzyme tested
Strains
L. paracasei L. plantarum L. brevis
62LP39 1A6M 11/20966 19/20711 4/116868 1C3M
Alkaline phosphatase 20 10 10 5 10 5
Esterase (C4) 10 5 5 0 5 20
Esterase lipase (C8) 10 10 5 10 10 10
Lipase (C14) 10 20 10 10 20 20
Leucine arylamidase >40 >40 >40 30 >40 >40
Valine arylamidase >40 >40 30 10 30 >40
Cystine arylamidase 20 20 10 0 20 20
Trypsin 5 5 0 0 5 0
𝛼-Chymotrypsin 0 0 5 5 5 5
Acid phosphatase 20 30 20 20 20 30
Napthol-AS-BI-phosphohydrolase 30 20 10 10 10 10
𝛼-Galactosidase 20 10 10 0 0 30
𝛽-Galactosidase >40 30 >40 10 20 >40
𝛽-Glucuronidase 0 0 0 0 0 0
𝛼-Glucosidase 30 30 20 0 20 30
𝛽-Glucosidase 30 10 30 20 30 30
N-Acetyl-glucosaminidase 5 0 0 5 0 0
𝛼-Mannosidase 0 0 0 0 0 0
𝛼-Fucosidase 0 5 0 0 0 0
Enzyme activity is expressed as the approximate nanomoles of hydrolysed substrate after 4 h of incubation at 37∘C.
Table 4: Antibiotic susceptibility of selected Lactobacillus strains.
Species Strain Antibiotic tested
∗
AM10 AmC30 VA30 TEC30 TE30 S10 K30 GM10 C30 E15 CIP30 RA30
L. paracasei 62LP39 S S R R S R R MS S S R S
1A6M S S R R S R R MS S S R S
L. plantarum
11/20966 S S R R S R R MS S S R S
19/20711 S S R R S R R MS S S R S
4/16868 S S R R S R R MS S S R S
L. brevis 1C3M S S R R S R R MS S S R S
∗Antibiotics: (AM) ampicillin; (AmC) amoxicillin/clavulanic acid; (VA) vancomycin; (TEC) teicoplanin; (TE) tetracycline; (S) streptomycin; (K) kanamycin;
(GM) gentamicin; (C) chloramphenicol; (E) erythromycin; (Cip) ciprofloxacin; (RA) rifampicin. R: resistant; S: sensitive; MS: moderately susceptible.
process of fermentation of foods and beverages by amino
acid decarboxylation. Bover-Cid andHolzapfel [16] suggested
that the capability to produce biogenic amines in a synthetic
mediummight be strain dependent rather than being related
to specific species. In our screening, none of the strains tested
was found to decarboxylate lysine, histidine, ornithine, or
tyrosine (data not shown), in agreement with other findings
[29, 47].
The Lactobacillus strains were assayed for their resistance
to 12 antibiotics using a disc diffusion method on MRS
agar plates under anaerobic conditions, and the results are
reported in Table 4. Within the group of antimicrobial agents
that inhibit the cell wall synthesis, all strains were resistant
to vancomycin and teicoplanin and susceptible to ampicillin
and amoxicillin/clavulanic acid. All strains were suscep-
tible to tetracycline, chloramphenicol, and erythromycin,
moderately susceptible to gentamycin, and resistant to strep-
tomycin and kanamycin. As for the antibiotics that inhibit
the nucleic acids synthesis, all strains were resistant to
ciprofloxacin and susceptible to rifampicin.
Our results are in substantial agreement with those
reported for L. plantarum and L. paracasei strains [26, 29],
although other authors observed a certain variability in
strains’ reaction to tetracycline [19, 48].
The resistance observed against some antibiotics tested
suggests that our strains would not be affected by therapies
using these antibiotics and might help maintain the natural
balance of intestinal microflora during antibiotic treatments
[49]. Resistance to some antibiotics such as aminoglycosides,
quinolones, and glycopeptides appears to be intrinsic for
Lactobacilli [50, 51]. In particular, vancomycin resistance is
well documented in Lactobacilli and it has been attributed to
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the synthesis of modified cell wall peptidoglycan precursors
that end in a depsipeptide d-alanine-d-lactate instead of
the dipeptide d-alanine-d-alanine, the target for vancomycin
activity [52]. Moreover, Klein et al. [50] showed that the
glycopeptide resistance in Lactobacillus strains is not of the
transmissible type.The strains tested in our work do not seem
to represent a source for transfer of genes encoding resistance,
since they were phenotypically susceptible to tetracycline,
erythromycin, and chloramphenicol, but the absence of
the genes needs to be confirmed genotypically. Comunian
et al. [48] recently found that tetracycline and erythromycin
resistance is not usually detected in strains originating from
cheeses produced in geographical areas (such as Sardinia
island) where no systematic use of antibiotics as growth pro-
moters was carried out over the years in animal husbandry.
Finally, none of the strains was found to be haemolytic
(data not shown), in agreement with previous studies [53].
4. Conclusions
In conclusion, our results indicate that some Lactobacil-
lus strains (particularly L. paracasei 62LP39, L. plantarum
11/20966 and 4/16868, and L. brevis 1C3M) could be con-
sidered appropriate probiotic candidates, due to resistance to
GIT simulated conditions, antimicrobial properties, adhesion
to human intestinal epithelial cell-line (Caco-2), and absence
of undesirable properties. They could be used as adjunct
cultures for contributing to the quality and health related
functional properties of dairy products; however, additional
studies are required to confirm in vivo this findings as well as
to assess the strains stability to manufacturing processes.
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